The Ott Lab publishes novel research on SARS-CoV-2 variants Read More

Our People

Sreekumar

Hello my name is Bharath and I am a post doc in Dr. Ott’s lab. I am currently working on HIV and T-cell biology.

Aviv

Gili grew up in Israel where she obtained her PhD in Microbiology from Tel-Aviv university. Her PhD research focused on characterization of Salmonella enterica serovar Infantis unique megaplasmid and its contribution to S. Infantis pathogenicity. In the Ott lab she studies the effect of HIV-1 and SARS-CoV-2 infection on intestinal stem cells function and the barrier integrity using human gut organoids. In her spare time, she enjoys skiing, playing tennis, roller skating, traveling, hiking and playing with her Dachshund puppy.

Divita

Tessa was born in the Bay Area and graduated from UC Berkeley with a B.A. in Molecular and Cellular Biology in December of 2020. In the Ott lab, she works on HIV transcription regulation. When she is not doing science, she enjoys doing gymnastics on horses.

Lyons

Danielle grew up in Iowa, got her B.S. in Microbiology at Colorado State University and completed her PhD in Microbiology at Yale University. Her thesis work focused on understanding transcriptional regulation of the Epstein-Barr Virus lytic cycle. In the Ott Lab, Danielle studies HIV transcription regulation. In her free time, she enjoys reading and playing polo on her horse Monkey.

Ott

Institute of Virology

Senior Vice President, Gladstone Institutes

Professor of Medicine, UCSF 

Melanie Ott earned her MD degree from University of Frankfurt in Germany and a PhD from the Picower Graduate School of Molecular Medicine in New York. In 1998, she started her own research group at the German Cancer Research Center in Heidelberg, Germany, in the department headed by tumor virologist and Nobel laureate Harald zur Hausen, studying HIV pathogenesis and a new emerging pathogen at the time, hepatitis C virus (HCV). 

In 2002, she moved her lab to the Gladstone Institutes, where she continued her work on HIV and HCV, and expanded her research into the host-virus interface in diseases such as Zika, influenza and SARS-CoV-2. She has focused much of her work on the role of reversible protein acetylation in HIV transcription (especially the viral Tat protein), and identifying new molecular targets for treatments and cure, new diagnostics and the potential for pan-viral therapeutics. 

Melanie is the Director of the Gladstone Institute of Virology Institute and Senior Vice President of the Gladstone Institutes, and a professor of medicine at University of California – San Francisco.  She is a recipient of NIH MERIT and DP1 Avantgarde Awards, an elected member of the Association of American Physicians and a Fellow of the American Academy of Microbiology.